SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001078782-18-000533
Filing Date
2018-05-11
Accepted
2018-05-11 17:23:12
Documents
1
Period of Report
2018-05-07
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ON FORM 8-K f8k051018_8k.htm 8-K 12817
  Complete submission text file 0001078782-18-000533.txt   14020
Mailing Address 45 ROCKEFELLER PLAZA 20TH FLOOR, STE 83 NEW YORK NY 10022
Business Address 45 ROCKEFELLER PLAZA 20TH FLOOR, STE 83 NEW YORK NY 10022 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Filer) CIK: 0001514946 (see all company filings)

IRS No.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54296 | Film No.: 18828009
SIC: 2834 Pharmaceutical Preparations